佛罗里达评分系统用于分层疑似儿童舍格伦病:一项横断面机器学习研究
在美国佛罗里达大学儿科风湿病科纳入217例疑似儿童舍格伦病患者,用潜在类别分析和多种机器学习模型识别患者类别并构建佛罗里达评分系统。潜在类别分析识别出三个类别:I类(干燥为主且检测阳性,n=27)、II类(高症状且检测阴性,n=98)、III类(低症状且检测阴性,n=92);机器学习模型能准确预测患者类别并一致地排序变量重要性。作者认为该评分系统是儿科医生友好的工具,可用于辅助分类和长期监测,但需要在更大的前瞻性儿科队列中验证。
要点
- 潜在类别分析识别出三个患者类别:I类干燥为主且检测阳性(n=27)、II类高症状且检测阴性(n=98)、III类低症状且检测阴性(n=92)。
- 机器学习模型能准确预测患者类别并一致地排序变量重要性,因果图学习选出关键特征构建佛罗里达评分系统。
- 作者发现一个高度症状性但血清学和诊断谱阴性的患者组,值得临床关注;唾液腺超声可能成为儿童小唾液腺活检的非侵入性替代。
核心结论
- 佛罗里达评分系统是儿科医生友好的工具,可用于辅助分类和长期监测疑似儿童舍格伦病。
- 由此产生的分层对临床管理、试验设计和病理生物学研究具有重要意义。
- 作者发现一个高度症状性但血清学和诊断谱阴性的患者组,值得临床关注。
- 作者进一步揭示唾液腺超声可能成为儿童小唾液腺活检的非侵入性替代。
- 佛罗里达评分系统需要在更大的前瞻性儿科队列中验证。
研究设计与样本
- 横断面研究,在美国佛罗里达州佛罗里达大学儿科风湿病科就诊的症状性患者中进行。
- 纳入标准为年龄小于18岁或症状发作在18岁之前;排除已确诊其他自身免疫病或明确病原微生物感染的患者。
- 2018年1月16日至2022年4月28日筛查448例,排除205例因症状发作晚于18岁后招募243例,再排除26例因确诊非舍格伦病,最终217例纳入分析。
- 诊断时中位年龄15岁(IQR 11-17);216例中155例(72%)为女性、61例(28%)为男性;212例中167例(79%)为白人;213例中20例(9%)为西班牙裔、拉丁裔或西班牙人。
- 使用潜在类别分析结合临床和实验室变量检测异质性患者类别,并用随机森林、梯度提升决策树、偏最小二乘判别分析、LASSO惩罚有序回归、人工神经网络和超级学习器等机器学习模型预测患者类别并排序变量重要性,因果图学习选择关键特征构建最终佛罗里达评分系统。
主要发现
- 潜在类别分析识别出三个不同患者类别:I类(干燥为主且检测阳性,n=27)、II类(高症状且检测阴性,n=98)、III类(低症状且检测阴性,n=92)。
- 机器学习模型准确预测患者类别并一致地排序变量重要性。
- 因果图模型发现构建佛罗里达评分系统的关键特征。
关键数值与推荐
- 佛罗里达评分系统基于因果图学习选出的关键特征构建,用于辅助分类和长期监测疑似儿童舍格伦病。
- 潜在类别分析识别三个类别:I类干燥为主且检测阳性(n=27)、II类高症状且检测阴性(n=98)、III类低症状且检测阴性(n=92)。
临床怎么用
- 作者认为佛罗里达评分系统是儿科医生友好的工具,可用于辅助分类和长期监测疑似儿童舍格伦病。
- 作者认为由此产生的分层对临床管理、试验设计和病理生物学研究具有重要意义。
- 作者指出高度症状性但血清学和诊断谱阴性的患者组值得临床关注。
- 作者揭示唾液腺超声可能成为儿童小唾液腺活检的非侵入性替代。
局限性
- 佛罗里达评分系统需要在更大的前瞻性儿科队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Childhood Sjögren's disease is a rare, underdiagnosed, and poorly-understood condition. By integrating machine learning models on a paediatric cohort in the USA, we aimed to develop a novel system (the Florida Scoring System) for stratifying symptomatic paediatric patients with suspected Sjögren's disease. METHODS: This cross-sectional study was done in symptomatic patients who visited the Department of Pediatric Rheumatology at the University of Florida, FL, USA. Eligible patients were younger than 18 years or had symptom onset before 18 years of age. Patients with confirmed diagnosis of another autoimmune condition or infection with a clear aetiological microorganism were excluded. Eligible patients underwent comprehensive examinations to rule out or diagnose childhood Sjögren's disease. We used latent class analysis with clinical and laboratory variables to detect heterogeneous patient classes. Machine learning models, including random forest, gradient-boosted decision tree, partial least square discriminatory analysis, least absolute shrinkage and selection operator-penalised ordinal regression, artificial neural network, and super learner were used to predict patient classes and rank the importance of variables. Causal graph learning selected key features to build the final Florida Scoring System. The predictors for all models were the clinical and laboratory variables and the outcome was the definition of patient classes. FINDINGS: Between Jan 16, 2018, and April 28, 2022, we screened 448 patients for inclusion. After excluding 205 patients due to symptom onset later than 18 years of age, we recruited 243 patients into our cohort. 26 patients were excluded because of confirmed diagnosis of a disorder other than Sjögren's disease, and 217 patients were included in the final analysis. Median age at diagnosis was 15 years (IQR 11-17). 155 (72%) of 216 patients were female and 61 (28%) were male, 167 (79%) of 212 were White, and 20 (9%) of 213 were Hispanic, Latino, or Spanish. The latent class analysis identified three distinct patient classes: class I (dryness dominant with positive tests, n=27), class II (high symptoms with negative tests, n=98), and class III (low symptoms with negative tests, n=92). Machine learning models accurately predicted patient class and ranked variable importance consistently. The causal graphical model discovered key features for constructing the Florida Scoring System. INTERPRETATION: The Florida Scoring System is a paediatrician-friendly tool that can be used to assist classification and long-term monitoring of suspected childhood Sjögren's disease. The resulting stratification has important implications for clinical management, trial design, and pathobiological research. We found a highly symptomatic patient group with negative serology and diagnostic profiles, which warrants clinical attention. We further revealed that salivary gland ultrasonography can be a non-invasive alternative to minor salivary gland biopsy in children. The Florida Scoring System requires validation in larger prospective paediatric cohorts. FUNDING: National Institute of Dental and Craniofacial Research, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Heart, Lung, and Blood Institute, and Sjögren's Foundation.
引用
- Zeng W, Thatayatikom A, Winn N, et al. The Florida Scoring System for stratifying children with suspected Sjögren's disease: a cross-sectional machine learning study. Lancet Rheumatol. 2024. PMID: 38658114. doi:10.1016/S2665-9913(24)00059-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。